1 min read
Add as a preferred source on Google

Rhythm Pharmaceuticals Shares Rise 5.4% by 12:22 p.m. ET

Viking Therapeutics was also part of speculation about two possible obesity-market targets.

Two unmarked medicine capsules sit on separate stone plinths / TokenPost.ai
Two unmarked medicine capsules sit on separate stone plinths / TokenPost.ai

Rhythm Pharmaceuticals shares were up 5.4% at 12:22 p.m. ET on Nov. 17 amid speculation that Eli Lilly was evaluating the drugmaker as a potential obesity-market acquisition target.

Viking Therapeutics was also part of the speculation, which involved two possible targets in the obesity market.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…